NASDAQ Stock Exchange News
Sign up for free!
Get instant access to all of our market news and analysis with our free REST API.
Latest news
Live response for past 24 hours
{
"meta": {
"found": 988,
"returned": 10,
"limit": 10,
"page": 1
},
"data": [
{
"uuid": "81f91bb4-7045-4116-9dac-862287df4fa4",
"title": "Cathie Wood's ARK Makes Bold Moves in Q1 2024, Coinbase Global Inc Sees Major Reduction",
"description": "ARK Investment Management's Latest 13F Filing Highlights Key Strategic Changes\n\nCathie Wood, the visionary founder of ARK Investment Management, has once again",
"keywords": "GuruFocus, Article, News, GuruFocus Research, COIN, TSLA, SQ, ROKU, PATH, ARKB, LAB, NTRA, SLGC, NVTAQ, TWLO",
"snippet": "ARK Investment Management's Latest 13F Filing Highlights Key Strategic Changes\n\nCathie Wood, the visionary founder of ARK Investment Management, has once again ...",
"url": "https://www.gurufocus.com/news/2413103/cathie-woods-ark-makes-bold-moves-in-q1-2024-coinbase-global-inc-sees-major-reduction",
"image_url": "https://s3.amazonaws.com/gurufocus_userupload/1781020000988065792.png",
"language": "en",
"published_at": "2024-04-18T19:01:34.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "TSLA",
"name": "Tesla, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 18.184376,
"sentiment_score": 0.1967,
"highlights": [
{
"highlight": "Key Position Increases\n\nWood's ARK has also ramped up its stakes in 62 existing holdings, with the most significant increases seen in:\n\n<em>Tesla</em> <em>Inc</em> (TSLA, Financial), with an additional 1,375,910 shares, bringing the total to 5,178,429 shares.",
"sentiment": 0.6666,
"highlighted_in": "main_text"
},
{
"highlight": "The top holdings include 8.12% in Coinbase Global Inc (COIN), 6.3% in <em>Tesla</em> <em>Inc</em> (TSLA, Financial), 5.89% in Block Inc (SQ, Financial), 5.67% in Roku Inc (ROKU, Financial), and 4.96% in UiPath Inc (PATH, Financial).",
"sentiment": -0.2732,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "ROKU",
"name": "Roku, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Communication Services",
"match_score": 18.168983,
"sentiment_score": 0.2616,
"highlights": [
{
"highlight": "<em>Roku</em> <em>Inc</em> (<em>ROKU</em>, Financial), with an additional 3,027,775 shares, bringing the total to 12,556,647. This adjustment marks a 31.77% increase in share count, with a total value of $818.32 million.",
"sentiment": 0.7964,
"highlighted_in": "main_text"
},
{
"highlight": "The top holdings include 8.12% in Coinbase Global Inc (COIN), 6.3% in Tesla Inc (TSLA, Financial), 5.89% in Block Inc (SQ, Financial), 5.67% in <em>Roku</em> <em>Inc</em> (<em>ROKU</em>, Financial), and 4.96% in UiPath Inc (PATH, Financial).",
"sentiment": -0.2732,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "NTRA",
"name": "Natera, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 22.287834,
"sentiment_score": 0.5574,
"highlights": [
{
"highlight": "<em>Natera</em> <em>Inc</em> (NTRA, Financial), with 322,384 shares, accounting for 0.2% of the portfolio and a total value of $29.49 million.",
"sentiment": 0.5574,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "COIN",
"name": "Coinbase Global, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "N/A",
"match_score": 98.99776,
"sentiment_score": 0.211767,
"highlights": [
{
"highlight": "The most notable reductions include:\n\n<em>Coinbase</em> <em>Global</em> <em>Inc</em> (<em>COIN</em>, Financial), with a reduction of 4,178,670 shares, leading to a -48.59% decrease in shares and a -4.31% impact on the portfolio. The stock traded at an average price of $179.97 during the quarter and has seen an 80.15% return over the past 3 months and a 28.79% year-to-date return.",
"sentiment": 0.5267,
"highlighted_in": "main_text"
},
{
"highlight": "The top holdings include 8.12% in <em>Coinbase</em> <em>Global</em> <em>Inc</em> (<em>COIN</em>), 6.3% in Tesla Inc (TSLA, Financial), 5.89% in Block Inc (SQ, Financial), 5.67% in Roku Inc (ROKU, Financial), and 4.96% in UiPath Inc (PATH, Financial).",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "Cathie Wood's ARK Makes Bold Moves in Q1 2024, <em>Coinbase</em> <em>Global</em> <em>Inc</em> Sees Major Reduction",
"sentiment": 0.3818,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "f1ef7078-77ac-4d51-8a21-f1a5763ca2f6",
"title": "Zscaler Positioned as a Leader in the 2024 Gartner® Magic Quadrant™ for Security Service Edge (SSE) for Third Straight Year",
"description": "SAN JOSE, Calif., April 18, 2024 (GLOBE NEWSWIRE) -- Zscaler, Inc. (NASDAQ: ZS), the leader in cloud security, today announced that it has been...",
"keywords": "Nasdaq:ZS, Zscaler, Inc., #cloudsecuirty, #zerotrust, #zerotrustsecurity",
"snippet": "SAN JOSE, Calif., April 18, 2024 (GLOBE NEWSWIRE) -- Zscaler, Inc. (NASDAQ: ZS), the leader in cloud security, today announced that it has been recognized as a ...",
"url": "https://www.globenewswire.com/news-release/2024/04/18/2865765/0/en/Zscaler-Positioned-as-a-Leader-in-the-2024-Gartner-Magic-Quadrant-for-Security-Service-Edge-SSE-for-Third-Straight-Year.html",
"image_url": "https://ml.globenewswire.com/Resource/Download/bcd2d61e-e35a-4ecb-90e0-bd8d1194fd0d",
"language": "en",
"published_at": "2024-04-18T18:36:00.000000Z",
"source": "globenewswire.com",
"relevance_score": null,
"entities": [
{
"symbol": "ZS",
"name": "Zscaler, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 57.232376,
"sentiment_score": 0.705057,
"highlights": [
{
"highlight": "., April 18, 2024 (GLOBE NEWSWIRE) -- <em>Zscaler</em>, <em>Inc</em>. (<em>NASDAQ</em>: <em>ZS</em>), the leader in cloud security, today announced that it has been recognized as a Leader in the 2024 Gartner Magic Quadrant for Security Service Edge (SSE) for the third year in a row.",
"sentiment": 0.5859,
"highlighted_in": "main_text"
},
{
"highlight": "Prior to the SSE Magic Quadrant, <em>Zscaler</em> was recognized as a leader for 10 consecutive years in the Magic Quadrant for Secure Web Gateway (SWG).\n\n\n\nGartner highlighted Zscaler’s strong revenue growth is outpacing the market, and that <em>Zscaler</em> is frequently seen on vendor shortlists for SSE.",
"sentiment": 0.8074,
"highlighted_in": "main_text"
},
{
"highlight": "Customers continue to choose <em>Zscaler</em> for its ability to provide true zero trust security on a global scale.\n\n“We’re proud that Gartner has recognized <em>Zscaler</em> as a Leader in the Magic Quadrant for SSE for all three years since the report’s inception,” said Jay Chaudhry, CEO, Chairman, and Founder of <em>Zscaler</em>.",
"sentiment": 0.9169,
"highlighted_in": "main_text"
},
{
"highlight": "In addition to being named a Leader in the 2024 Gartner Magic Quadrant for SSE, <em>Zscaler</em> has also been recognized by customers. The company is honored of its consistently high rating in Gartner Peer Insights, currently at 4.5/5, and is the most reviewed vendor in the SSE segment.",
"sentiment": 0.5859,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Zscaler</em> consistently achieves an NPS score over 70, far above the average for SaaS vendors.\n\nA complimentary copy of the 2024 Gartner Magic Quadrant for SSE report can be downloaded here.\n\nGartner Disclaimer\n\nGartner, Magic Quadrant for Security Service Edge, 17 April 2024, Thomas Lintemuth, Charlie Winckless, Dale Koeppen.",
"sentiment": 0.6486,
"highlighted_in": "main_text"
},
{
"highlight": "About <em>Zscaler</em>\n\n<em>Zscaler</em> (<em>NASDAQ</em>: <em>ZS</em>) accelerates digital transformation so customers can be more agile, efficient, resilient, and secure. The <em>Zscaler</em> Zero Trust Exchange™ platform protects thousands of customers from cyberattacks and data loss by securely connecting users, devices, and applications in any location.",
"sentiment": 0.8801,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Zscaler</em> Positioned as a Leader in the 2024 Gartner® Magic Quadrant™ for Security Service Edge (SSE) for Third Straight Year",
"sentiment": 0.5106,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "405a248f-be2c-4623-9b5c-9281a9547159",
"title": "Kevin O'Leary Says Working For Steve Jobs Was Brutal — 'He Was Not a Nice Guy,' But O'Leary Still Admires Him Anyway",
"description": "",
"keywords": "",
"snippet": "\"Shark Tank\" star Kevin O'Leary recalled working for Apple Inc. Co-Founder Steve Jobs during a recent interview posted on LinkedIn. While most remember Jobs for...",
"url": "https://finance.yahoo.com/news/kevin-oleary-says-working-steve-183332785.html?.tsrc=rss",
"image_url": "https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png",
"language": "en",
"published_at": "2024-04-18T18:33:32.000000Z",
"source": "finance.yahoo.com",
"relevance_score": null,
"entities": [
{
"symbol": "AAPL",
"name": "Apple Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 15.122753,
"sentiment_score": 0.185625,
"highlights": [
{
"highlight": "\"Shark Tank\" star Kevin O'Leary recalled working for <em>Apple</em> <em>Inc</em>. Co-Founder Steve Jobs during a recent interview posted on LinkedIn. While most remember Jobs for building the technology and innovation giant now a part of most Americans' everyday lives, O'Leary said he remembers him for a different reason.",
"sentiment": 0.3818,
"highlighted_in": "main_text"
},
{
"highlight": "But one of O'Leary's business partners in the runup to that acquisition was <em>Apple</em>.\n\n\"We, The Learning Company, were his largest provider for educational software when [<em>Apple</em>] wanted to get into schools with the Mac,\" O'Leary said. This meant O'Leary and Jobs regularly met to make that happen.\n\nDon't Miss:\n\n\"He was not a nice guy.",
"sentiment": -0.0904,
"highlighted_in": "main_text"
},
{
"highlight": "Trending: Invest alongside execs from Uber, Facebook and <em>Apple</em> in this wellness app Transforming a $5.6 TRILLION dollar industry.\n\n\"I admired him for his steal vision and getting where he needed to go. He didn't let people get in the way,\" O'Leary wrote.\n\nWhile largely part of his Mr.",
"sentiment": 0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "The startup world can be brutal and unintuitive, but when founders or investors get it right, it can result in a big payday for those involved or changing the world like what happened with <em>Apple</em>.",
"sentiment": 0.1779,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "340a9279-56ca-4778-85e8-7ae87250c6c4",
"title": "Intuit Mailchimp and Fast Company Announce the Forward Awards to Recognize the Best in Email Marketing",
"description": "NEW YORK, April 18, 2024 /PRNewswire/ -- Intuit Mailchimp, in partnership with Fast Company, is pleased to announce a new awards program to honor the best email marketing campaigns from around the...",
"keywords": "Markets",
"snippet": "NEW YORK, April 18, 2024 /PRNewswire/ -- Intuit Mailchimp, in partnership with Fast Company, is pleased to announce a new awards program to honor the best email...",
"url": "https://www.marketscreener.com/quote/stock/INTUIT-INC-23277275/news/Intuit-Mailchimp-and-Fast-Company-Announce-the-Forward-Awards-to-Recognize-the-Best-in-Email-Marketi-46471690/",
"image_url": "https://www.marketscreener.com/images/twitter_MS_fdblanc.png",
"language": "en",
"published_at": "2024-04-18T18:21:07.000000Z",
"source": "marketscreener.com",
"relevance_score": null,
"entities": [
{
"symbol": "INTU",
"name": "Intuit Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 56.536854,
"sentiment_score": 0.626214,
"highlights": [
{
"highlight": "NEW YORK, April 18, 2024 /PRNewswire/ -- <em>Intuit</em> Mailchimp, in partnership with Fast Company, is pleased to announce a new awards program to honor the best email marketing campaigns from around the world.",
"sentiment": 0.9231,
"highlighted_in": "main_text"
},
{
"highlight": "\"At Mailchimp, we have a great view of how email provides marketers a unique channel to craft innovative messages and draw in audiences,\" said Megan Spellman, Director of Brand Experience at <em>Intuit</em> Mailchimp. \"The Forward Awards are an opportunity to showcase that creativity more broadly and encourage further innovation.\"",
"sentiment": 0.9583,
"highlighted_in": "main_text"
},
{
"highlight": "Sponsored by <em>Intuit</em>. No purchase necessary. Void where prohibited. Contest begins at 12:00:01 p.m. ET on 04/18/24 and ends at 11:59:59 p.m. ET on 05/24/24. Terms and conditions apply. Please refer to the Official Rules & Eligibility for complete details and full contest terms and conditions.",
"sentiment": 0.0258,
"highlighted_in": "main_text"
},
{
"highlight": "About <em>Intuit</em> Mailchimp\n\n<em>Intuit</em> Mailchimp is an email and marketing automations platform for growing businesses. We empower millions of customers around the world to start and grow their businesses with world-class marketing technology, award-winning customer support, and inspiring content.",
"sentiment": 0.7351,
"highlighted_in": "main_text"
},
{
"highlight": "In 2021, Mailchimp was acquired by <em>Intuit</em> <em>Inc</em>. (<em>Nasdaq</em>: <em>INTU</em>), the global financial technology platform that makes <em>Intuit</em> TurboTax, Credit Karma, QuickBooks, and Mailchimp.\n\nAbout <em>Intuit</em>\n\n<em>Intuit</em> is the global financial technology platform that powers prosperity for the people and communities we serve.",
"sentiment": 0.3818,
"highlighted_in": "main_text"
},
{
"highlight": "Please visit us at Intuit.com and find us on social for the latest information about <em>Intuit</em> and our products and services.\n\nView original content:https://www.prnewswire.com/news-releases/<em>intuit</em>-mailchimp-and-fast-company-announce-the-forward-awards-to-recognize-the-best-in-email-marketing-302121330.html\n\nSOURCE Fast Company",
"sentiment": 0.5574,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Intuit</em> Mailchimp and Fast Company Announce the Forward Awards to Recognize the Best in Email Marketing",
"sentiment": 0.802,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "4bfbe1e5-44eb-4ca9-9f5c-185ccb78b28a",
"title": "You can't hold a good weed stock down (Nasdaq: CGC) (NASDAQ: TLRY) (NASDAQ: ACB)",
"description": "",
"keywords": "",
"snippet": "April 18, 2024 (Investorideas.com Newswire) Investorideas.com, a global news source and expert investing resource covering cannabis stocks reports on trading in...",
"url": "https://www.investorideas.com/news/2024/cannabis/04181Stocks.asp",
"image_url": "https://www.investorideas.com/images/potcastsrss.jpg",
"language": "en",
"published_at": "2024-04-18T18:20:00.000000Z",
"source": "investorideas.com",
"relevance_score": null,
"entities": [
{
"symbol": "APHA",
"name": "Tilray, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 41.722214,
"sentiment_score": 0.8271,
"highlights": [
{
"highlight": "<em>Tilray</em> Brands, Inc. (Nasdaq: TLRY) (TSX: TLRY) is trading at $1.7450, up marginally at 0.0250 (+1.45%) on the NASDAQ. News from the company's subsidiary , Montauk Brewing Company , came out today announcing the return of Project 4:20 India Pale Ale, a limited release crafted to celebrate and support green charities during Earth Month and beyond.",
"sentiment": 0.8271,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "TLRY",
"name": "Tilray, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 131.08954,
"sentiment_score": 0.3424,
"highlights": [
{
"highlight": "<em>Tilray</em> Brands, Inc. (<em>Nasdaq</em>: <em>TLRY</em>) (TSX: <em>TLRY</em>) is trading at $1.7450, up marginally at 0.0250 (+1.45%) on the NASDAQ. News from the company's subsidiary , Montauk Brewing Company , came out today announcing the return of Project 4:20 India Pale Ale, a limited release crafted to celebrate and support green charities during Earth Month and beyond.",
"sentiment": 0.8271,
"highlighted_in": "main_text"
},
{
"highlight": "You can't hold a good weed stock down (Nasdaq: CGC) (<em>NASDAQ</em>: <em>TLRY</em>) (NASDAQ: ACB)",
"sentiment": -0.1423,
"highlighted_in": "title"
}
]
},
{
"symbol": "CGC",
"name": "Canopy Growth Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 116.94386,
"sentiment_score": 0.35346,
"highlights": [
{
"highlight": "<em>Canopy</em> <em>Growth</em> <em>Corporation</em> (TSX: WEED) (<em>Nasdaq</em>: <em>CGC</em>) is trading at $7.91, spiking $1.43 for a 21.94% gain, with a high of $8.03 on the NASDAQ. The company's most recent news was results of the shareholder meeting and an update on strategy.",
"sentiment": 0.5267,
"highlighted_in": "main_text"
},
{
"highlight": "\"On October 25, 2022, <em>Canopy</em> <em>Growth</em> previously announced a strategy to accelerate its entry into the U.S. cannabis industry and unleash the value of its full U.S. cannabis ecosystem through the creation of a new U.S.-domiciled holding company, Canopy USA, LLC (\"Canopy USA\").",
"sentiment": 0.5423,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Canopy</em> <em>Growth</em> is expected to deconsolidate the financial results of Canopy USA and have a non-controlling interest in Canopy USA, which will be accounted for as an equity method (fair value) investment.\"",
"sentiment": 0.4588,
"highlighted_in": "main_text"
},
{
"highlight": "Through these \"stepping stone\" transactions, <em>Canopy</em> <em>Growth</em> will be strategically repositioned to capitalize on the benefits of complete ownership and control of its U.S.",
"sentiment": 0.3818,
"highlighted_in": "main_text"
},
{
"highlight": "You can't hold a good weed stock down (<em>Nasdaq</em>: <em>CGC</em>) (NASDAQ: TLRY) (NASDAQ: ACB)",
"sentiment": -0.1423,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "7f780c10-7bed-4c6d-9198-c60e645020e5",
"title": "What You Need To Know Ahead of Meta's Earnings Report",
"description": "Meta is set to report first-quarter earnings on April 24, and analysts expect revenue and income to rise year-over-year but fall from the prior quarter. They also see solid ad revenue growth.",
"keywords": "",
"snippet": "Analyst Estimates for Q1 2024 Q4 2023 Q1 2023 Revenue $36.24 billion $40.11 billion $28.65 billion Adjusted Earnings Per Share $5.55 $6.51 $3.33 Adjusted Net In...",
"url": "https://www.investopedia.com/meta-q1-fy-2024-earnings-preview-8630822",
"image_url": "https://www.investopedia.com/thmb/uK2KT3-XzyixmxzN5tvjYUxuHMw=/1500x0/filters:no_upscale():max_bytes(150000):strip_icc()/GettyImages-19347599681-be440b77cc5240708ede41a11ccee251.jpg",
"language": "en",
"published_at": "2024-04-18T18:10:10.000000Z",
"source": "investopedia.com",
"relevance_score": null,
"entities": [
{
"symbol": "GOOGL",
"name": "Alphabet Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Communication Services",
"match_score": 16.341976,
"sentiment_score": 0.4939,
"highlights": [
{
"highlight": "The analysts wrote that they \"see a strengthening digital advertising environment heading into 1Q results,\" highlighting Meta and <em>Alphabet</em> (<em>GOOGL</em>) as major benefactors.",
"sentiment": 0.4939,
"highlighted_in": "main_text"
}
]
}
],
"similar": [
{
"uuid": "bd2af1ae-80f0-4ba1-aab0-7c96d2b7dff2",
"title": "American Express (AXP) Earnings Announcement - Will Credit Card Giant Surpass Expectations?",
"description": "American Express Company (AXP) will publish its first-quarter earnings on April 19. After missing the earnings and revenue expectations in the previous quarter, will the credit card giant be able...",
"keywords": "Business News, Stocks, Finance",
"snippet": "American Express Company (AXP) will publish its first-quarter earnings on April 19. After missing the earnings and revenue expectations in the previous quarter,...",
"url": "https://www.entrepreneur.com/finance/american-express-axp-earnings-announcement-will-credit/472902",
"image_url": "https://assets.entrepreneur.com/providers/stocknews/hero-image-stocknews-472902.jpeg?format=pjeg&auto=webp",
"language": "en",
"published_at": "2024-04-18T11:15:13.000000Z",
"source": "entrepreneur.com",
"relevance_score": null,
"entities": [
{
"symbol": "^GSPC",
"name": "S&P 500",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "index",
"industry": "N/A",
"match_score": 13.780369,
"sentiment_score": 0.6486,
"highlights": [
{
"highlight": "Year-to-date, AXP has gained 16.93%, versus a 5.64% rise in the benchmark <em>S</em>&<em>P</em> <em>500</em> index during the same period.\n\nAbout the Author: Dipanjan Banchur\n\nSince he was in grade school, Dipanjan was interested in the stock market. This led to him obtaining a master’s degree in Finance and Accounting.",
"sentiment": 0.6486,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "^SPX",
"name": "S&P 500 INDEX",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "index",
"industry": "N/A",
"match_score": 19.447224,
"sentiment_score": 0.6486,
"highlights": [
{
"highlight": "Year-to-date, AXP has gained 16.93%, versus a 5.64% rise in the benchmark <em>S</em>&<em>P</em> <em>500</em> <em>index</em> during the same period.\n\nAbout the Author: Dipanjan Banchur\n\nSince he was in grade school, Dipanjan was interested in the stock market. This led to him obtaining a master’s degree in Finance and Accounting.",
"sentiment": 0.6486,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "ATLC",
"name": "Atlanticus Holdings Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 25.040964,
"sentiment_score": -0.3102,
"highlights": [
{
"highlight": "(QFIN), <em>Atlanticus</em> <em>Holdings</em> <em>Corporation</em> (ATLC), and EZCORP, Inc. (EZPW). For exploring more Buy-rated Comsumer Financial Services stocks, click here.\n\nWhat To Do Next?\n\nDiscover 10 widely held stocks that our proprietary model shows have tremendous downside potential.",
"sentiment": -0.3102,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "EZPW",
"name": "EZCORP, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 19.73514,
"sentiment_score": -0.3102,
"highlights": [
{
"highlight": "(QFIN), Atlanticus Holdings Corporation (ATLC), and <em>EZCORP</em>, <em>Inc</em>. (EZPW). For exploring more Buy-rated Comsumer Financial Services stocks, click here.\n\nWhat To Do Next?\n\nDiscover 10 widely held stocks that our proprietary model shows have tremendous downside potential.",
"sentiment": -0.3102,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "ATLCP",
"name": "Atlanticus Holdings Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "N/A",
"match_score": 25.034445,
"sentiment_score": -0.3102,
"highlights": [
{
"highlight": "(QFIN), <em>Atlanticus</em> <em>Holdings</em> <em>Corporation</em> (ATLC), and EZCORP, Inc. (EZPW). For exploring more Buy-rated Comsumer Financial Services stocks, click here.\n\nWhat To Do Next?\n\nDiscover 10 widely held stocks that our proprietary model shows have tremendous downside potential.",
"sentiment": -0.3102,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "AXP",
"name": "American Express Company",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 61.9383,
"sentiment_score": 0.33578,
"highlights": [
{
"highlight": "<em>American</em> <em>Express</em> <em>Company</em> (AXP) will publish its first-quarter earnings on April 19. After missing the earnings and revenue expectations in the previous quarter, will the credit card giant be able...\n\nThis story originally appeared on StockNews\n\n<em>American</em> <em>Express</em> <em>Company</em> (AXP) will publish its first-quarter earnings on April 19.",
"sentiment": 0.1027,
"highlighted_in": "main_text"
},
{
"highlight": "<em>American</em> <em>Express</em> <em>Company</em> (AXP) will unveil its first-quarter results on April 19. Wall Street anticipates the credit card giant to post higher revenue and earnings in the first quarter. With AXP’s earnings expected shortly, I have discussed why waiting for an opportune entry point in the stock could be wise.",
"sentiment": 0.8126,
"highlighted_in": "main_text"
},
{
"highlight": "How Does <em>American</em> <em>Express</em> <em>Company</em> (AXP) Stack Up Against Its Peers?\n\nAXP has an overall POWR Rating of C, equating to a Neutral rating. You may check out these A and B-rated stocks within the Consumer Financial Services industry: Qifu Technology, Inc. (QFIN), Atlanticus Holdings Corporation (ATLC), and EZCORP, Inc. (EZPW).",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "The post <em>American</em> <em>Express</em> (AXP) Earnings Announcement - Will Credit Card Giant Surpass Expectations? appeared first on StockNews.com",
"sentiment": 0.3818,
"highlighted_in": "main_text"
},
{
"highlight": "<em>American</em> <em>Express</em> (AXP) Earnings Announcement - Will Credit Card Giant Surpass Expectations?",
"sentiment": 0.3818,
"highlighted_in": "title"
}
]
},
{
"symbol": "AXP.SN",
"name": "American Express Company",
"exchange": null,
"exchange_long": null,
"country": "cl",
"type": "equity",
"industry": "Financial Services",
"match_score": 61.937508,
"sentiment_score": 0.33578,
"highlights": [
{
"highlight": "<em>American</em> <em>Express</em> <em>Company</em> (AXP) will publish its first-quarter earnings on April 19. After missing the earnings and revenue expectations in the previous quarter, will the credit card giant be able...\n\nThis story originally appeared on StockNews\n\n<em>American</em> <em>Express</em> <em>Company</em> (AXP) will publish its first-quarter earnings on April 19.",
"sentiment": 0.1027,
"highlighted_in": "main_text"
},
{
"highlight": "<em>American</em> <em>Express</em> <em>Company</em> (AXP) will unveil its first-quarter results on April 19. Wall Street anticipates the credit card giant to post higher revenue and earnings in the first quarter. With AXP’s earnings expected shortly, I have discussed why waiting for an opportune entry point in the stock could be wise.",
"sentiment": 0.8126,
"highlighted_in": "main_text"
},
{
"highlight": "How Does <em>American</em> <em>Express</em> <em>Company</em> (AXP) Stack Up Against Its Peers?\n\nAXP has an overall POWR Rating of C, equating to a Neutral rating. You may check out these A and B-rated stocks within the Consumer Financial Services industry: Qifu Technology, Inc. (QFIN), Atlanticus Holdings Corporation (ATLC), and EZCORP, Inc. (EZPW).",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "The post <em>American</em> <em>Express</em> (AXP) Earnings Announcement - Will Credit Card Giant Surpass Expectations? appeared first on StockNews.com",
"sentiment": 0.3818,
"highlighted_in": "main_text"
},
{
"highlight": "<em>American</em> <em>Express</em> (AXP) Earnings Announcement - Will Credit Card Giant Surpass Expectations?",
"sentiment": 0.3818,
"highlighted_in": "title"
}
]
},
{
"symbol": "AEC1.DE",
"name": "American Express Company",
"exchange": null,
"exchange_long": null,
"country": "de",
"type": "equity",
"industry": "Financial Services",
"match_score": 61.935226,
"sentiment_score": 0.33578,
"highlights": [
{
"highlight": "<em>American</em> <em>Express</em> <em>Company</em> (AXP) will publish its first-quarter earnings on April 19. After missing the earnings and revenue expectations in the previous quarter, will the credit card giant be able...\n\nThis story originally appeared on StockNews\n\n<em>American</em> <em>Express</em> <em>Company</em> (AXP) will publish its first-quarter earnings on April 19.",
"sentiment": 0.1027,
"highlighted_in": "main_text"
},
{
"highlight": "<em>American</em> <em>Express</em> <em>Company</em> (AXP) will unveil its first-quarter results on April 19. Wall Street anticipates the credit card giant to post higher revenue and earnings in the first quarter. With AXP’s earnings expected shortly, I have discussed why waiting for an opportune entry point in the stock could be wise.",
"sentiment": 0.8126,
"highlighted_in": "main_text"
},
{
"highlight": "How Does <em>American</em> <em>Express</em> <em>Company</em> (AXP) Stack Up Against Its Peers?\n\nAXP has an overall POWR Rating of C, equating to a Neutral rating. You may check out these A and B-rated stocks within the Consumer Financial Services industry: Qifu Technology, Inc. (QFIN), Atlanticus Holdings Corporation (ATLC), and EZCORP, Inc. (EZPW).",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "The post <em>American</em> <em>Express</em> (AXP) Earnings Announcement - Will Credit Card Giant Surpass Expectations? appeared first on StockNews.com",
"sentiment": 0.3818,
"highlighted_in": "main_text"
},
{
"highlight": "<em>American</em> <em>Express</em> (AXP) Earnings Announcement - Will Credit Card Giant Surpass Expectations?",
"sentiment": 0.3818,
"highlighted_in": "title"
}
]
},
{
"symbol": "AXP.MX",
"name": "American Express Company",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Financial Services",
"match_score": 61.936367,
"sentiment_score": 0.33578,
"highlights": [
{
"highlight": "<em>American</em> <em>Express</em> <em>Company</em> (AXP) will publish its first-quarter earnings on April 19. After missing the earnings and revenue expectations in the previous quarter, will the credit card giant be able...\n\nThis story originally appeared on StockNews\n\n<em>American</em> <em>Express</em> <em>Company</em> (AXP) will publish its first-quarter earnings on April 19.",
"sentiment": 0.1027,
"highlighted_in": "main_text"
},
{
"highlight": "<em>American</em> <em>Express</em> <em>Company</em> (AXP) will unveil its first-quarter results on April 19. Wall Street anticipates the credit card giant to post higher revenue and earnings in the first quarter. With AXP’s earnings expected shortly, I have discussed why waiting for an opportune entry point in the stock could be wise.",
"sentiment": 0.8126,
"highlighted_in": "main_text"
},
{
"highlight": "How Does <em>American</em> <em>Express</em> <em>Company</em> (AXP) Stack Up Against Its Peers?\n\nAXP has an overall POWR Rating of C, equating to a Neutral rating. You may check out these A and B-rated stocks within the Consumer Financial Services industry: Qifu Technology, Inc. (QFIN), Atlanticus Holdings Corporation (ATLC), and EZCORP, Inc. (EZPW).",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "The post <em>American</em> <em>Express</em> (AXP) Earnings Announcement - Will Credit Card Giant Surpass Expectations? appeared first on StockNews.com",
"sentiment": 0.3818,
"highlighted_in": "main_text"
},
{
"highlight": "<em>American</em> <em>Express</em> (AXP) Earnings Announcement - Will Credit Card Giant Surpass Expectations?",
"sentiment": 0.3818,
"highlighted_in": "title"
}
]
},
{
"symbol": "0R3C.L",
"name": "American Express Company",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 61.935455,
"sentiment_score": 0.33578,
"highlights": [
{
"highlight": "<em>American</em> <em>Express</em> <em>Company</em> (AXP) will publish its first-quarter earnings on April 19. After missing the earnings and revenue expectations in the previous quarter, will the credit card giant be able...\n\nThis story originally appeared on StockNews\n\n<em>American</em> <em>Express</em> <em>Company</em> (AXP) will publish its first-quarter earnings on April 19.",
"sentiment": 0.1027,
"highlighted_in": "main_text"
},
{
"highlight": "<em>American</em> <em>Express</em> <em>Company</em> (AXP) will unveil its first-quarter results on April 19. Wall Street anticipates the credit card giant to post higher revenue and earnings in the first quarter. With AXP’s earnings expected shortly, I have discussed why waiting for an opportune entry point in the stock could be wise.",
"sentiment": 0.8126,
"highlighted_in": "main_text"
},
{
"highlight": "How Does <em>American</em> <em>Express</em> <em>Company</em> (AXP) Stack Up Against Its Peers?\n\nAXP has an overall POWR Rating of C, equating to a Neutral rating. You may check out these A and B-rated stocks within the Consumer Financial Services industry: Qifu Technology, Inc. (QFIN), Atlanticus Holdings Corporation (ATLC), and EZCORP, Inc. (EZPW).",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "The post <em>American</em> <em>Express</em> (AXP) Earnings Announcement - Will Credit Card Giant Surpass Expectations? appeared first on StockNews.com",
"sentiment": 0.3818,
"highlighted_in": "main_text"
},
{
"highlight": "<em>American</em> <em>Express</em> (AXP) Earnings Announcement - Will Credit Card Giant Surpass Expectations?",
"sentiment": 0.3818,
"highlighted_in": "title"
}
]
}
]
}
]
},
{
"uuid": "0411afc5-cf2f-447d-bcfb-3ad6f0919b0f",
"title": "ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Perion Network Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action “ PERI By Investing.com",
"description": "ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Perion Network Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action “ PERI",
"keywords": "",
"snippet": "NEW YORK, April 18, 2024 (GLOBE NEWSWIRE) --\n\nWHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf o...",
"url": "https://www.investing.com/news/press-releases/rosen-trusted-investor-counsel-encourages-perion-network-ltd-investors-to-secure-counsel-before-important-deadline-in-securities-class-action--peri-93CH-3385283",
"image_url": "https://i-invdn-com.investing.com/news/news_pile_69x52._800x533_L_1419494209.jpg",
"language": "en",
"published_at": "2024-04-18T18:08:04.000000Z",
"source": "investing.com",
"relevance_score": null,
"entities": [
{
"symbol": "MSFT",
"name": "Microsoft Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 12.810883,
"sentiment_score": 0.0412,
"highlights": [
{
"highlight": "DETAILS OF THE CASE: According to the lawsuit, defendants made false and/or misleading statements and/or failed to disclose that: (1) Perion's search advertising business was not a reliable and significant growth driver and was in fact in decline; (2) Perion's long-term relationship with <em>Microsoft</em> (NASDAQ: ) and search services agreement would not provide",
"sentiment": -0.3257,
"highlighted_in": "main_text"
},
{
"highlight": "stability for Perion's search advertising business; (3) there was an increased risk of <em>Microsoft</em> acting to unilaterally change its advertising pricing and mechanisms to the detriment of Perion while the search services agreement was in place; (4) Perion's AI technology and Microsoft's investment in ChatGPT would not protect or grow Perion's search",
"sentiment": 0.4081,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "PERI",
"name": "Perion Network Ltd.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Communication Services",
"match_score": 126.42679,
"sentiment_score": 0.3383,
"highlights": [
{
"highlight": "NEW YORK, April 18, 2024 (GLOBE NEWSWIRE) --\n\nWHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of <em>Perion</em> <em>Network</em> <em>Ltd</em>. (NASDAQ: NASDAQ: ) between February 9, 2021 and April 5, 2024, both dates inclusive (the Class Period).",
"sentiment": -0.2263,
"highlighted_in": "main_text"
},
{
"highlight": "ROSEN, TRUSTED INVESTOR COUNSEL, Encourages <em>Perion</em> <em>Network</em> <em>Ltd</em>. Investors to Secure Counsel Before Important Deadline in Securities Class Action “ PERI By Investing.com",
"sentiment": 0.9029,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "f67bfc6b-1aeb-4a05-8684-4c2516706aa2",
"title": "ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Perion Network Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action – PERI",
"description": "NEW YORK, April 18, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on...",
"keywords": "The Rosen Law Firm PA, Perion Network Ltd., Rosen Law Firm, NASDAQ: PERI, Microsoft, Class Action",
"snippet": "NEW YORK, April 18, 2024 (GLOBE NEWSWIRE) --\n\nWHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf o...",
"url": "https://www.globenewswire.com/news-release/2024/04/18/2865746/673/en/ROSEN-TRUSTED-INVESTOR-COUNSEL-Encourages-Perion-Network-Ltd-Investors-to-Secure-Counsel-Before-Important-Deadline-in-Securities-Class-Action-PERI.html",
"image_url": "https://ml.globenewswire.com/Resource/Download/745335af-3a3a-4fb5-84c0-fdedc9adf092",
"language": "en",
"published_at": "2024-04-18T17:56:00.000000Z",
"source": "globenewswire.com",
"relevance_score": null,
"entities": [
{
"symbol": "MSFT",
"name": "Microsoft Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 9.81576,
"sentiment_score": 0.0412,
"highlights": [
{
"highlight": "DETAILS OF THE CASE: According to the lawsuit, defendants made false and/or misleading statements and/or failed to disclose that: (1) Perion’s search advertising business was not a reliable and significant growth driver and was in fact in decline; (2) Perion’s long-term relationship with <em>Microsoft</em> and search services agreement would not provide stability",
"sentiment": -0.3257,
"highlighted_in": "main_text"
},
{
"highlight": "for Perion’s search advertising business; (3) there was an increased risk of <em>Microsoft</em> acting to unilaterally change its advertising pricing and mechanisms to the detriment of Perion while the search services agreement was in place; (4) Perion’s AI technology and Microsoft’s investment in ChatGPT would not protect or grow Perion’s search advertising",
"sentiment": 0.4081,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "PERI",
"name": "Perion Network Ltd.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Communication Services",
"match_score": 140.60114,
"sentiment_score": 0.3383,
"highlights": [
{
"highlight": "NEW YORK, April 18, 2024 (GLOBE NEWSWIRE) --\n\nWHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of <em>Perion</em> <em>Network</em> <em>Ltd</em>. (<em>NASDAQ</em>: <em>PERI</em>) between February 9, 2021 and April 5, 2024, both dates inclusive (the “Class Period”).",
"sentiment": -0.2263,
"highlighted_in": "main_text"
},
{
"highlight": "ROSEN, TRUSTED INVESTOR COUNSEL, Encourages <em>Perion</em> <em>Network</em> <em>Ltd</em>. Investors to Secure Counsel Before Important Deadline in Securities Class Action – PERI",
"sentiment": 0.9029,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "f0d8f757-35ab-4da6-83f9-31492681f5e0",
"title": "Class Action Lawsuit Filed on Behalf of AST SpaceMobile, Inc. (ASTS) Investors – Nationally Ranked Investors’ Rights Firm Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact t",
"description": "ATLANTA, April 18, 2024 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against AST SpaceMobile, Inc. (“SpaceMobile” or the...",
"keywords": "Holzer & Holzer, Class Action",
"snippet": "ATLANTA, April 18, 2024 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against AST SpaceMobile, Inc. (“SpaceMobile” or the “Company...",
"url": "https://www.globenewswire.com/news-release/2024/04/18/2865564/0/en/Class-Action-Lawsuit-Filed-on-Behalf-of-AST-SpaceMobile-Inc-ASTS-Investors-Nationally-Ranked-Investors-Rights-Firm-Holzer-Holzer-LLC-Encourages-Investors-With-Significant-Losses-to.html",
"image_url": "https://ml.globenewswire.com/Resource/Download/ded75474-e608-4c33-b664-8dc46382852f",
"language": "en",
"published_at": "2024-04-18T14:38:00.000000Z",
"source": "globenewswire.com",
"relevance_score": null,
"entities": [
{
"symbol": "ASTS",
"name": "AST SpaceMobile, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "N/A",
"match_score": 148.62778,
"sentiment_score": -0.10025,
"highlights": [
{
"highlight": "ATLANTA, April 18, 2024 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against <em>AST</em> <em>SpaceMobile</em>, <em>Inc</em>. (“SpaceMobile” or the “Company”) (<em>NASDAQ</em>: <em>ASTS</em>).",
"sentiment": -0.2263,
"highlighted_in": "main_text"
},
{
"highlight": "Class Action Lawsuit Filed on Behalf of <em>AST</em> <em>SpaceMobile</em>, <em>Inc</em>. (<em>ASTS</em>) Investors – Nationally Ranked Investors’ Rights Firm Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact t",
"sentiment": 0.0258,
"highlighted_in": "title"
}
]
},
{
"symbol": "ASTSW",
"name": "AST SpaceMobile, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "N/A",
"match_score": 104.73456,
"sentiment_score": -0.10025,
"highlights": [
{
"highlight": "ATLANTA, April 18, 2024 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against <em>AST</em> <em>SpaceMobile</em>, <em>Inc</em>. (“SpaceMobile” or the “Company”) (NASDAQ: ASTS).",
"sentiment": -0.2263,
"highlighted_in": "main_text"
},
{
"highlight": "Class Action Lawsuit Filed on Behalf of <em>AST</em> <em>SpaceMobile</em>, <em>Inc</em>. (ASTS) Investors – Nationally Ranked Investors’ Rights Firm Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact t",
"sentiment": 0.0258,
"highlighted_in": "title"
}
]
}
]
}
]
},
{
"uuid": "d5fad545-7892-425b-8b25-ca0f6b0ec68c",
"title": "Global CAR T-Cell Therapy Market Size To Worth USD 21.92 Billion By 2033 | CAGR of 17.72%",
"description": "The Global CAR T-Cell Therapy Market Size was Valued at USD 4.29 Billion in 2023 and the Worldwide CAR T-Cell Therapy Market Size is Expected to Reach USD...",
"keywords": "SPHERICAL INSIGHTS LLP, CAR T-Cell Therapy Market, CAR T-Cell Therapy Market Size, CAR T-Cell Therapy Share, T-Cell Therapy Market Growth, Analysis, Price",
"snippet": "New York, United States, April 18, 2024 (GLOBE NEWSWIRE) -- The Global CAR T-Cell Therapy Market Size is to Grow from USD 4.29 Billion in 2023 to USD 21.92 Bill...",
"url": "https://www.globenewswire.com/news-release/2024/04/18/2865749/0/en/Global-CAR-T-Cell-Therapy-Market-Size-To-Worth-USD-21-92-Billion-By-2033-CAGR-of-17-72.html",
"image_url": "https://ml.globenewswire.com/Resource/Download/b27a94e8-407e-46ae-a5c2-47bb2a1c8a2e",
"language": "en",
"published_at": "2024-04-18T18:00:00.000000Z",
"source": "globenewswire.com",
"relevance_score": null,
"entities": [
{
"symbol": "BLUE",
"name": "bluebird bio, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 19.497591,
"sentiment_score": 0,
"highlights": [
{
"highlight": "., Sangamo Therapeutics, <em>bluebird</em> <em>bio</em>, <em>Inc</em>., Johnson & Johnson Services, Inc., Merck & Co., Inc., and Other key vendors.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "GILD",
"name": "Gilead Sciences, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 18.004692,
"sentiment_score": 0.516,
"highlights": [
{
"highlight": "., <em>Gilead</em> <em>Sciences</em>, <em>Inc</em>., Bristol-Myers Squibb Company, JW Therapeutics (Shanghai) Co., Ltd., Sangamo Therapeutics, bluebird bio, Inc., Johnson & Johnson Services, Inc., Merck & Co., Inc., and Other key vendors.",
"sentiment": 0.516,
"highlighted_in": "main_text"
}
]
}
],
"similar": [
{
"uuid": "a195654d-f3c3-4a72-846f-b2681d161a1e",
"title": "Global Anti-hypertensive Drug Market Size To Exceed USD 50 Billion By 2033 | CAGR of 7.18%",
"description": "The Global Anti-hypertensive Drug Market Size was Valued at USD 25 Billion in 2023 and the Worldwide Anti-hypertensive Drug Market Size is expected to...",
"keywords": "SPHERICAL INSIGHTS LLP, Anti-hypertensive Drug Market, Anti-hypertensive Drug Size, Anti-hypertensive Drug Share, Anti-hypertensive Drug Trend, Price, Si",
"snippet": "New York, United States, April 18, 2024 (GLOBE NEWSWIRE) -- The Global Anti-hypertensive Drug Market Size is to Grow from USD 25 Billion in 2023 to USD 50 Billi...",
"url": "https://www.globenewswire.com/news-release/2024/04/18/2865556/0/en/Global-Anti-hypertensive-Drug-Market-Size-To-Exceed-USD-50-Billion-By-2033-CAGR-of-7-18.html",
"image_url": "https://ml.globenewswire.com/Resource/Download/b27a94e8-407e-46ae-a5c2-47bb2a1c8a2e",
"language": "en",
"published_at": "2024-04-18T14:30:00.000000Z",
"source": "globenewswire.com",
"relevance_score": null,
"entities": [
{
"symbol": "ABT",
"name": "Abbott Laboratories",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 14.678223,
"sentiment_score": 0,
"highlights": [
{
"highlight": "Major vendors in the global anti-hypertensive drug market are <em>Abbott</em> <em>Laboratories</em>, AstraZeneca Plc., Dr. Reddy’s Laboratories, Sanofi, Johnson & Johnson Services Inc., Pfizer Inc., Merck & Co. Inc., Medtronic Inc., GlaxoSmithKline Plc., Stryker Corporation, Orthofix, Takeda Pharmaceutical Co., Bayer AG, Noden Pharma DAC, and Others Key Players.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "MRK",
"name": "Merck & Co., Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 11.61124,
"sentiment_score": 0,
"highlights": [
{
"highlight": "., <em>Merck</em> & <em>Co</em>. <em>Inc</em>., Medtronic Inc., GlaxoSmithKline Plc., Stryker Corporation, Orthofix, Takeda Pharmaceutical Co., Bayer AG, Noden Pharma DAC, and Others Key Players.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "SYK",
"name": "Stryker Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 11.985333,
"sentiment_score": 0.4939,
"highlights": [
{
"highlight": "., <em>Stryker</em> <em>Corporation</em>, Orthofix, Takeda Pharmaceutical Co., Bayer AG, Noden Pharma DAC, and Others Key Players.\n\nGet Discount At @ https://www.sphericalinsights.com/request-discount/3938\n\nRecent Developments\n\nIn September 2022, Korea Hanmi launched a high-blood pressure blockbuster drug Amosartan in China under the brand name Meiyaping.",
"sentiment": 0.4939,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "GSK",
"name": "GlaxoSmithKline plc",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 12.43379,
"sentiment_score": 0,
"highlights": [
{
"highlight": "., <em>GlaxoSmithKline</em> <em>Plc</em>., Stryker Corporation, Orthofix, Takeda Pharmaceutical Co., Bayer AG, Noden Pharma DAC, and Others Key Players.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "PFE",
"name": "Pfizer Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 8.916427,
"sentiment_score": 0,
"highlights": [
{
"highlight": "., <em>Pfizer</em> <em>Inc</em>., Merck & Co. Inc., Medtronic Inc., GlaxoSmithKline Plc., Stryker Corporation, Orthofix, Takeda Pharmaceutical Co., Bayer AG, Noden Pharma DAC, and Others Key Players.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "PFE-WI",
"name": "Pfizer, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "N/A",
"match_score": 8.916427,
"sentiment_score": 0,
"highlights": [
{
"highlight": "., <em>Pfizer</em> <em>Inc</em>., Merck & Co. Inc., Medtronic Inc., GlaxoSmithKline Plc., Stryker Corporation, Orthofix, Takeda Pharmaceutical Co., Bayer AG, Noden Pharma DAC, and Others Key Players.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "JNJ",
"name": "Johnson & Johnson",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 10.988247,
"sentiment_score": 0,
"highlights": [
{
"highlight": "Reddy’s Laboratories, Sanofi, <em>Johnson</em> & <em>Johnson</em> Services Inc., Pfizer Inc., Merck & Co. Inc., Medtronic Inc., GlaxoSmithKline Plc., Stryker Corporation, Orthofix, Takeda Pharmaceutical Co., Bayer AG, Noden Pharma DAC, and Others Key Players.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "ZEG.DE",
"name": "AstraZeneca PLC",
"exchange": null,
"exchange_long": null,
"country": "de",
"type": "equity",
"industry": "Healthcare",
"match_score": 11.025997,
"sentiment_score": 0,
"highlights": [
{
"highlight": "Major vendors in the global anti-hypertensive drug market are Abbott Laboratories, <em>AstraZeneca</em> <em>Plc</em>., Dr. Reddy’s Laboratories, Sanofi, Johnson & Johnson Services Inc., Pfizer Inc., Merck & Co. Inc., Medtronic Inc., GlaxoSmithKline Plc., Stryker Corporation, Orthofix, Takeda Pharmaceutical Co., Bayer AG, Noden Pharma DAC, and Others Key Players.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "PFE.DE",
"name": "Pfizer Inc.",
"exchange": null,
"exchange_long": null,
"country": "de",
"type": "equity",
"industry": "Healthcare",
"match_score": 8.916463,
"sentiment_score": 0,
"highlights": [
{
"highlight": "., <em>Pfizer</em> <em>Inc</em>., Merck & Co. Inc., Medtronic Inc., GlaxoSmithKline Plc., Stryker Corporation, Orthofix, Takeda Pharmaceutical Co., Bayer AG, Noden Pharma DAC, and Others Key Players.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "6MK.DE",
"name": "Merck & Co., Inc.",
"exchange": null,
"exchange_long": null,
"country": "de",
"type": "equity",
"industry": "Healthcare",
"match_score": 11.61097,
"sentiment_score": 0,
"highlights": [
{
"highlight": "., <em>Merck</em> & <em>Co</em>. <em>Inc</em>., Medtronic Inc., GlaxoSmithKline Plc., Stryker Corporation, Orthofix, Takeda Pharmaceutical Co., Bayer AG, Noden Pharma DAC, and Others Key Players.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "SYK.DE",
"name": "Stryker Corporation",
"exchange": null,
"exchange_long": null,
"country": "de",
"type": "equity",
"industry": "Healthcare",
"match_score": 11.984202,
"sentiment_score": 0.4939,
"highlights": [
{
"highlight": "., <em>Stryker</em> <em>Corporation</em>, Orthofix, Takeda Pharmaceutical Co., Bayer AG, Noden Pharma DAC, and Others Key Players.\n\nGet Discount At @ https://www.sphericalinsights.com/request-discount/3938\n\nRecent Developments\n\nIn September 2022, Korea Hanmi launched a high-blood pressure blockbuster drug Amosartan in China under the brand name Meiyaping.",
"sentiment": 0.4939,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "GS7.DE",
"name": "GlaxoSmithKline plc",
"exchange": null,
"exchange_long": null,
"country": "de",
"type": "equity",
"industry": "Healthcare",
"match_score": 12.433371,
"sentiment_score": 0,
"highlights": [
{
"highlight": "., <em>GlaxoSmithKline</em> <em>Plc</em>., Stryker Corporation, Orthofix, Takeda Pharmaceutical Co., Bayer AG, Noden Pharma DAC, and Others Key Players.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "MRK.PA",
"name": "Merck & Co., Inc.",
"exchange": null,
"exchange_long": null,
"country": "fr",
"type": "equity",
"industry": "Healthcare",
"match_score": 11.610867,
"sentiment_score": 0,
"highlights": [
{
"highlight": "., <em>Merck</em> & <em>Co</em>. <em>Inc</em>., Medtronic Inc., GlaxoSmithKline Plc., Stryker Corporation, Orthofix, Takeda Pharmaceutical Co., Bayer AG, Noden Pharma DAC, and Others Key Players.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "AZN",
"name": "AstraZeneca PLC",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 11.025945,
"sentiment_score": 0,
"highlights": [
{
"highlight": "Major vendors in the global anti-hypertensive drug market are Abbott Laboratories, <em>AstraZeneca</em> <em>Plc</em>., Dr. Reddy’s Laboratories, Sanofi, Johnson & Johnson Services Inc., Pfizer Inc., Merck & Co. Inc., Medtronic Inc., GlaxoSmithKline Plc., Stryker Corporation, Orthofix, Takeda Pharmaceutical Co., Bayer AG, Noden Pharma DAC, and Others Key Players.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "AZNCF",
"name": "AstraZeneca PLC",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 11.025894,
"sentiment_score": 0,
"highlights": [
{
"highlight": "Major vendors in the global anti-hypertensive drug market are Abbott Laboratories, <em>AstraZeneca</em> <em>Plc</em>., Dr. Reddy’s Laboratories, Sanofi, Johnson & Johnson Services Inc., Pfizer Inc., Merck & Co. Inc., Medtronic Inc., GlaxoSmithKline Plc., Stryker Corporation, Orthofix, Takeda Pharmaceutical Co., Bayer AG, Noden Pharma DAC, and Others Key Players.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "AZNN.MX",
"name": "AstraZeneca PLC",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 11.024634,
"sentiment_score": 0,
"highlights": [
{
"highlight": "Major vendors in the global anti-hypertensive drug market are Abbott Laboratories, <em>AstraZeneca</em> <em>Plc</em>., Dr. Reddy’s Laboratories, Sanofi, Johnson & Johnson Services Inc., Pfizer Inc., Merck & Co. Inc., Medtronic Inc., GlaxoSmithKline Plc., Stryker Corporation, Orthofix, Takeda Pharmaceutical Co., Bayer AG, Noden Pharma DAC, and Others Key Players.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "PFE.MX",
"name": "Pfizer Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 8.915514,
"sentiment_score": 0,
"highlights": [
{
"highlight": "., <em>Pfizer</em> <em>Inc</em>., Merck & Co. Inc., Medtronic Inc., GlaxoSmithKline Plc., Stryker Corporation, Orthofix, Takeda Pharmaceutical Co., Bayer AG, Noden Pharma DAC, and Others Key Players.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "MRK.MX",
"name": "Merck & Co., Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 11.610405,
"sentiment_score": 0,
"highlights": [
{
"highlight": "., <em>Merck</em> & <em>Co</em>. <em>Inc</em>., Medtronic Inc., GlaxoSmithKline Plc., Stryker Corporation, Orthofix, Takeda Pharmaceutical Co., Bayer AG, Noden Pharma DAC, and Others Key Players.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "SYK.MX",
"name": "Stryker Corporation",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 11.983335,
"sentiment_score": 0.4939,
"highlights": [
{
"highlight": "., <em>Stryker</em> <em>Corporation</em>, Orthofix, Takeda Pharmaceutical Co., Bayer AG, Noden Pharma DAC, and Others Key Players.\n\nGet Discount At @ https://www.sphericalinsights.com/request-discount/3938\n\nRecent Developments\n\nIn September 2022, Korea Hanmi launched a high-blood pressure blockbuster drug Amosartan in China under the brand name Meiyaping.",
"sentiment": 0.4939,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "GLAXF",
"name": "GlaxoSmithKline plc",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 12.433015,
"sentiment_score": 0,
"highlights": [
{
"highlight": "., <em>GlaxoSmithKline</em> <em>Plc</em>., Stryker Corporation, Orthofix, Takeda Pharmaceutical Co., Bayer AG, Noden Pharma DAC, and Others Key Players.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "AZN.L",
"name": "AstraZeneca PLC",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "Healthcare",
"match_score": 11.024668,
"sentiment_score": 0,
"highlights": [
{
"highlight": "Major vendors in the global anti-hypertensive drug market are Abbott Laboratories, <em>AstraZeneca</em> <em>Plc</em>., Dr. Reddy’s Laboratories, Sanofi, Johnson & Johnson Services Inc., Pfizer Inc., Merck & Co. Inc., Medtronic Inc., GlaxoSmithKline Plc., Stryker Corporation, Orthofix, Takeda Pharmaceutical Co., Bayer AG, Noden Pharma DAC, and Others Key Players.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "GSK.L",
"name": "GlaxoSmithKline plc",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "Healthcare",
"match_score": 12.432943,
"sentiment_score": 0,
"highlights": [
{
"highlight": "., <em>GlaxoSmithKline</em> <em>Plc</em>., Stryker Corporation, Orthofix, Takeda Pharmaceutical Co., Bayer AG, Noden Pharma DAC, and Others Key Players.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "0A4J.L",
"name": "AstraZeneca PLC",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 11.02478,
"sentiment_score": 0,
"highlights": [
{
"highlight": "Major vendors in the global anti-hypertensive drug market are Abbott Laboratories, <em>AstraZeneca</em> <em>Plc</em>., Dr. Reddy’s Laboratories, Sanofi, Johnson & Johnson Services Inc., Pfizer Inc., Merck & Co. Inc., Medtronic Inc., GlaxoSmithKline Plc., Stryker Corporation, Orthofix, Takeda Pharmaceutical Co., Bayer AG, Noden Pharma DAC, and Others Key Players.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "0R2S.L",
"name": "Stryker Corporation",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 11.983002,
"sentiment_score": 0.4939,
"highlights": [
{
"highlight": "., <em>Stryker</em> <em>Corporation</em>, Orthofix, Takeda Pharmaceutical Co., Bayer AG, Noden Pharma DAC, and Others Key Players.\n\nGet Discount At @ https://www.sphericalinsights.com/request-discount/3938\n\nRecent Developments\n\nIn September 2022, Korea Hanmi launched a high-blood pressure blockbuster drug Amosartan in China under the brand name Meiyaping.",
"sentiment": 0.4939,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "S1YK34.SA",
"name": "Stryker Corporation",
"exchange": null,
"exchange_long": null,
"country": "br",
"type": "equity",
"industry": "Healthcare",
"match_score": 11.982218,
"sentiment_score": 0.4939,
"highlights": [
{
"highlight": "., <em>Stryker</em> <em>Corporation</em>, Orthofix, Takeda Pharmaceutical Co., Bayer AG, Noden Pharma DAC, and Others Key Players.\n\nGet Discount At @ https://www.sphericalinsights.com/request-discount/3938\n\nRecent Developments\n\nIn September 2022, Korea Hanmi launched a high-blood pressure blockbuster drug Amosartan in China under the brand name Meiyaping.",
"sentiment": 0.4939,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "DJNJ2.BA",
"name": "Johnson & Johnson",
"exchange": null,
"exchange_long": null,
"country": "ar",
"type": "equity",
"industry": "Healthcare",
"match_score": 10.987434,
"sentiment_score": 0,
"highlights": [
{
"highlight": "Reddy’s Laboratories, Sanofi, <em>Johnson</em> & <em>Johnson</em> Services Inc., Pfizer Inc., Merck & Co. Inc., Medtronic Inc., GlaxoSmithKline Plc., Stryker Corporation, Orthofix, Takeda Pharmaceutical Co., Bayer AG, Noden Pharma DAC, and Others Key Players.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "DJNJ3.BA",
"name": "Johnson & Johnson",
"exchange": null,
"exchange_long": null,
"country": "ar",
"type": "equity",
"industry": "Healthcare",
"match_score": 10.987434,
"sentiment_score": 0,
"highlights": [
{
"highlight": "Reddy’s Laboratories, Sanofi, <em>Johnson</em> & <em>Johnson</em> Services Inc., Pfizer Inc., Merck & Co. Inc., Medtronic Inc., GlaxoSmithKline Plc., Stryker Corporation, Orthofix, Takeda Pharmaceutical Co., Bayer AG, Noden Pharma DAC, and Others Key Players.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "PFED.BA",
"name": "PFIZER INC",
"exchange": null,
"exchange_long": null,
"country": "ar",
"type": "equity",
"industry": "N/A",
"match_score": 8.915553,
"sentiment_score": 0,
"highlights": [
{
"highlight": "., <em>Pfizer</em> <em>Inc</em>., Merck & Co. Inc., Medtronic Inc., GlaxoSmithKline Plc., Stryker Corporation, Orthofix, Takeda Pharmaceutical Co., Bayer AG, Noden Pharma DAC, and Others Key Players.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "MRKD.BA",
"name": "MERCK & CO INC",
"exchange": null,
"exchange_long": null,
"country": "ar",
"type": "equity",
"industry": "N/A",
"match_score": 11.609396,
"sentiment_score": 0,
"highlights": [
{
"highlight": "., <em>Merck</em> & <em>Co</em>. <em>Inc</em>., Medtronic Inc., GlaxoSmithKline Plc., Stryker Corporation, Orthofix, Takeda Pharmaceutical Co., Bayer AG, Noden Pharma DAC, and Others Key Players.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "BAYN.BA",
"name": "BAYER AG",
"exchange": null,
"exchange_long": null,
"country": "ar",
"type": "equity",
"industry": "N/A",
"match_score": 10.164299,
"sentiment_score": 0.4939,
"highlights": [
{
"highlight": "., <em>Bayer</em> <em>AG</em>, Noden Pharma DAC, and Others Key Players.\n\nGet Discount At @ https://www.sphericalinsights.com/request-discount/3938\n\nRecent Developments\n\nIn September 2022, Korea Hanmi launched a high-blood pressure blockbuster drug Amosartan in China under the brand name Meiyaping.",
"sentiment": 0.4939,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "ABT.SN",
"name": "Abbott Laboratories",
"exchange": null,
"exchange_long": null,
"country": "cl",
"type": "equity",
"industry": "Healthcare",
"match_score": 14.673801,
"sentiment_score": 0,
"highlights": [
{
"highlight": "Major vendors in the global anti-hypertensive drug market are <em>Abbott</em> <em>Laboratories</em>, AstraZeneca Plc., Dr. Reddy’s Laboratories, Sanofi, Johnson & Johnson Services Inc., Pfizer Inc., Merck & Co. Inc., Medtronic Inc., GlaxoSmithKline Plc., Stryker Corporation, Orthofix, Takeda Pharmaceutical Co., Bayer AG, Noden Pharma DAC, and Others Key Players.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "PFECL.SN",
"name": "PFIZER INC",
"exchange": null,
"exchange_long": null,
"country": "cl",
"type": "equity",
"industry": "N/A",
"match_score": 8.915467,
"sentiment_score": 0,
"highlights": [
{
"highlight": "., <em>Pfizer</em> <em>Inc</em>., Merck & Co. Inc., Medtronic Inc., GlaxoSmithKline Plc., Stryker Corporation, Orthofix, Takeda Pharmaceutical Co., Bayer AG, Noden Pharma DAC, and Others Key Players.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "ABTCL.SN",
"name": "Abbott Laboratories",
"exchange": null,
"exchange_long": null,
"country": "cl",
"type": "equity",
"industry": "N/A",
"match_score": 14.673801,
"sentiment_score": 0,
"highlights": [
{
"highlight": "Major vendors in the global anti-hypertensive drug market are <em>Abbott</em> <em>Laboratories</em>, AstraZeneca Plc., Dr. Reddy’s Laboratories, Sanofi, Johnson & Johnson Services Inc., Pfizer Inc., Merck & Co. Inc., Medtronic Inc., GlaxoSmithKline Plc., Stryker Corporation, Orthofix, Takeda Pharmaceutical Co., Bayer AG, Noden Pharma DAC, and Others Key Players.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "MRK.SN",
"name": "Merck & Co., Inc.",
"exchange": null,
"exchange_long": null,
"country": "cl",
"type": "equity",
"industry": "Healthcare",
"match_score": 11.609015,
"sentiment_score": 0,
"highlights": [
{
"highlight": "., <em>Merck</em> & <em>Co</em>. <em>Inc</em>., Medtronic Inc., GlaxoSmithKline Plc., Stryker Corporation, Orthofix, Takeda Pharmaceutical Co., Bayer AG, Noden Pharma DAC, and Others Key Players.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "PFE.SN",
"name": "Pfizer Inc.",
"exchange": null,
"exchange_long": null,
"country": "cl",
"type": "equity",
"industry": "Healthcare",
"match_score": 8.915467,
"sentiment_score": 0,
"highlights": [
{
"highlight": "., <em>Pfizer</em> <em>Inc</em>., Merck & Co. Inc., Medtronic Inc., GlaxoSmithKline Plc., Stryker Corporation, Orthofix, Takeda Pharmaceutical Co., Bayer AG, Noden Pharma DAC, and Others Key Players.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
}
]
}
]
},
{
"uuid": "65a897f3-0b18-4197-b67e-174fbccd3920",
"title": "Caribou Biosciences: Two Clinical Data Updates In 2024 Could Bring Value (NASDAQ:CRBU)",
"description": "Caribou Biosciences, Inc. expects promising phase 1 studies on CB-010 and CB-011 for various lymphoma and myeloma treatments by Q2 2024. Click for my CRBU update.",
"keywords": "",
"snippet": "Solskin\n\nCaribou Biosciences, Inc. (NASDAQ:CRBU) is gearing up to present initial dose expansion data from its ongoing phase 1 ANTLER study. This particular ear...",
"url": "https://seekingalpha.com/article/4684523-caribou-biosciences-two-clinical-data-updates-in-2024-could-bring-value",
"image_url": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/168166178/image_168166178.jpg?io=getty-c-w1536",
"language": "en",
"published_at": "2024-04-18T17:59:29.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "GILD",
"name": "Gilead Sciences, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 14.023783,
"sentiment_score": 0.918,
"highlights": [
{
"highlight": "Another autologous CD-19 directed CAR-T already approved to treat LBCL patients would be Yescarta from <em>Gilead</em> <em>Sciences</em>, <em>Inc</em>. (GILD).\n\nThe ultimate goal is for Caribou to use its technology to advance the ability of its allogenic CAR-T platform technology to end up being safer and more effective compared to that of autologous CAR-T.",
"sentiment": 0.918,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "4bd7231a-63d1-453d-ab40-15ea80237d4a",
"title": "Ally Financial Reports Upbeat Earnings, Joins Badger Meter, Genuine Parts And Other Big Stocks Moving Higher On Thursday - Ally Financial (NYSE:ALLY), Apogee Enterprises (NASDAQ:APOG)",
"description": "",
"keywords": "",
"snippet": "Loading... Loading...\n\nU.S. stocks were lower, with the Nasdaq Composite falling over 50 points on Thursday.\n\nShares of Ally Financial Inc. ALLY rose sharply du...",
"url": "https://www.benzinga.com/news/24/04/38321505/ally-financial-reports-upbeat-earnings-joins-badger-meter-genuine-parts-and-other-big-stocks-moving",
"image_url": "https://cdn.benzinga.com/files/images/story/2024/04/18/Image16.jpeg?width=1200&height=800&fit=crop",
"language": "en",
"published_at": "2024-04-18T17:58:52.000000Z",
"source": "benzinga.com",
"relevance_score": null,
"entities": [
{
"symbol": "APOG",
"name": "Apogee Enterprises, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Industrials",
"match_score": 95.707504,
"sentiment_score": 0.44785,
"highlights": [
{
"highlight": "<em>Apogee</em> <em>Enterprises</em>, <em>Inc</em> APOG surged 8.1% to $60.42 following upbeat quarterly earnings.\n\nsurged 8.1% to $60.42 following upbeat quarterly earnings. ManpowerGroup Inc . MAN gained 7.1% to $75.03 following strong second-quarter guidance.\n\n. gained 7.1% to $75.03 following strong second-quarter guidance. Snap Inc.",
"sentiment": 0.8957,
"highlighted_in": "main_text"
},
{
"highlight": "Ally Financial Reports Upbeat Earnings, Joins Badger Meter, Genuine Parts And Other Big Stocks Moving Higher On Thursday - Ally Financial (NYSE:ALLY), <em>Apogee</em> <em>Enterprises</em> (<em>NASDAQ:APOG</em>)",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "UAL",
"name": "United Airlines Holdings, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Industrials",
"match_score": 32.780846,
"sentiment_score": 0,
"highlights": [
{
"highlight": "<em>United</em> <em>Airlines</em> <em>Holdings</em>, <em>Inc</em> . UAL jumped 4.6% to $50.99 after multiple analysts raised their price targets on the stock.\n\n. jumped 4.6% to $50.99 after multiple analysts raised their price targets on the stock.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "CGC",
"name": "Canopy Growth Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 30.30426,
"sentiment_score": 0.9001,
"highlights": [
{
"highlight": "<em>Canopy</em> <em>Growth</em> <em>Corporation</em> CGC shares gained 21.2% to $7.86.\n\nshares gained 21.2% to $7.86. Humacyte, Inc. HUMA shares rose 13.9% to $3.5550.\n\nshares rose 13.9% to $3.5550. Trump Media & Technology Group Corp. DJT jumped 13.4% to $29.92.",
"sentiment": 0.9001,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "IRDM",
"name": "Iridium Communications Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Communication Services",
"match_score": 34.585953,
"sentiment_score": 0,
"highlights": [
{
"highlight": "<em>Iridium</em> <em>Communications</em> <em>Inc</em> . IRDM climbed 8.5% to $26.81 after the company reported better-than-expected first-quarter financial results.\n\n. climbed 8.5% to $26.81 after the company reported better-than-expected first-quarter financial results. Apogee Enterprises, Inc APOG surged 8.1% to $60.42 following upbeat quarterly earnings.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "NFLX",
"name": "Netflix, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Communication Services",
"match_score": 9.334065,
"sentiment_score": 0,
"highlights": [
{
"highlight": "Now Read This: <em>Netflix</em> Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call\n\nDouble exposure of business woman are trading USA stock market by using digital tablet",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "HUMA",
"name": "Humacyte, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "N/A",
"match_score": 39.695168,
"sentiment_score": 0.8271,
"highlights": [
{
"highlight": "<em>Humacyte</em>, <em>Inc</em>. <em>HUMA</em> shares rose 13.9% to $3.5550.\n\nshares rose 13.9% to $3.5550. Trump Media & Technology Group Corp. DJT jumped 13.4% to $29.92. The company in a filing explained to shareholders how to prevent shares from being loaned for a short interest position.\n\njumped 13.4% to $29.92.",
"sentiment": 0.8271,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
}
]
}
Sentiment
Live response for past 24 hours
{
"meta": {
"returned": 1,
"limit": 10
},
"data": [
{
"key": "NASDAQ",
"total_documents": 1580,
"sentiment_avg": 0.24392792641190575
}
]
}
Other details
Country
- us
- 5,275